Mark Kowalski - Net Worth and Insider Trading

Mark Kowalski Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Mark Kowalski owns 2 companies in total, including Sierra Oncology Inc (SRRA) , and Arbutus Biopharma Corp (ABUS) .

Click here to see the complete history of Mark Kowalski’s form 4 insider trades.

Insider Ownership Summary of Mark Kowalski

Ticker Comapny Transaction Date Type of Owner
SRRA Sierra Oncology Inc 2017-01-03 Chief Medical Officer
ABUS Arbutus Biopharma Corp 2015-01-01 Sr VP & Chief Medical Officer

Mark Kowalski Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Mark Kowalski Ownership Network

Ownership Network List of Mark Kowalski

No Data

Ownership Network Relation of Mark Kowalski


Mark Kowalski Owned Company Details

What does Sierra Oncology Inc do?

Who are the key executives at Sierra Oncology Inc?

Mark Kowalski is the Chief Medical Officer of Sierra Oncology Inc. Other key executives at Sierra Oncology Inc include director & 10 percent owner Vivo Opportunity Fund Holdings, L.p. , Chief Reg & Tech Ops Officer William D. Turner , and General Counsel Mary Christina Thomson .

Sierra Oncology Inc (SRRA) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Sierra Oncology Inc (SRRA) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Sierra Oncology Inc (SRRA) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Sierra Oncology Inc (SRRA)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Sierra Oncology Inc Insider Transactions

No Available Data

Mark Kowalski Mailing Address

Above is the net worth, insider trading, and ownership report for Mark Kowalski. You might contact Mark Kowalski via mailing address: C/o Arbutus Biopharma Corp., 100-8900 Glenlyon Parkway, Burnaby A1 V5j 5j8.

Discussions on Mark Kowalski

No discussions yet.